Epidemiology of pancreatic cancer
Cancer of the pancreas remains one of the deadliest cancer types. Based on the GLOBOCAN 2012 estimates, pancreatic cancer causes more than 331000 deaths per year, ranking as the seventh leading cause of cancer death in both sexes together. Globally, about 338000 people had pancreatic cancer in 2012,...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 22; no. 44; pp. 9694 - 9705 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Baishideng Publishing Group Inc
28.11.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Cancer of the pancreas remains one of the deadliest cancer types. Based on the GLOBOCAN 2012 estimates, pancreatic cancer causes more than 331000 deaths per year, ranking as the seventh leading cause of cancer death in both sexes together. Globally, about 338000 people had pancreatic cancer in 2012, making it the 11
most common cancer. The highest incidence and mortality rates of pancreatic cancer are found in developed countries. Trends for pancreatic cancer incidence and mortality varied considerably in the world. A known cause of pancreatic cancer is tobacco smoking. This risk factor is likely to explain some of the international variations and gender differences. The overall five-year survival rate is about 6% (ranges from 2% to 9%), but this vary very small between developed and developing countries. To date, the causes of pancreatic cancer are still insufficiently known, although certain risk factors have been identified, such as smoking, obesity, genetics, diabetes, diet, inactivity. There are no current screening recommendations for pancreatic cancer, so primary prevention is of utmost importance. A better understanding of the etiology and identifying the risk factors is essential for the primary prevention of this disease. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 Author contributions: All authors equally contributed to this paper with conception and design of the study, literature review and analysis, drafting and critical revision and editing, and final approval of the final version. Telephone: +381-34-306800 Fax: +381-34-306800 Correspondence to: Milena Ilic, MD, PhD, Faculty of Medical Sciences, University of Kragujevac, S. Markovica 69, 34000 Kragujevac, Serbia. drmilenailic@yahoo.com |
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.v22.i44.9694 |